Cardiovascular Risk Assessment in Patients With Type 2 Diabetes Mellitus
Bibliographic Data
| ID | 22320245 |
|---|---|
| Authors | Mirsada Terzic, Mirsada Avdagic-Terzic (University of Bihać), Zarina Babic (University of Bihać), Azra Burekovic (0000-0002-1158-510X, University of Sarajevo) |
| Year | 2022 |
| Volume | 34 |
| Issue | 3 |
| Pages | 180 |
| Publication date | 2022-01-01 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Materia Socio Medica (JOURNAL) |
| Journal identifiers | ISSN: 1512-7680 • E-ISSN: 1986-597X |
| Publisher | ScopeMed (PUBLISHER • TR) |
| DOI | 10.5455/msm.2022.34.180-183 |
| PMID | 36310744 |
| OpenAlex | W4295835893 |
| Language | EN |
Background: It is well known that unregulated type 2 diabetes mellitus (T2DM) is a major risk factor for the development of cardiovascular incidents. Early risk assessment, specially for coronary artery disease, is important to initiate therapeutic strategies to reduce ardiovascular risk. Objective: To examine the cardiovascular risk in patients with diabetes mellitus in relation to age, sex, disease duration, glucoregulation and applied therapy. Methods: A study involving 64 patients divided into appropriate groups according to age, sex, disease duration, glucoregulation, and applied therapy. Cardiovascular risk was calculated using the SCORE table for cardiovascular risk assessment. Results: Examining the cardiovascular risk in patients with diabetes mellitus, it was found that cardiovascular risk increases with age (rho = 0.458; p = 0.0001; p
Cardiology · Coronary artery disease · Diabetes mellitus · Disease · Framingham Risk Score · Risk factor · Type 2 Diabetes Mellitus · Biological Research and Disease Studies · Diabetes Treatment and Management · Diabetes, Cardiovascular Risks, and Lipoproteins · Medicine · Endocrinology · Internal Medicine
| Highly cited | No |
|---|